A team of scientists has developed a new AI-based foundation model that can give insights into disease-causing mutations and ...

AI has demonstrated remarkable proficiency in diagnosing various eye diseases, including diabetic retinopathy, glaucoma, and ...

A unique collaboration between electrical engineers and ophthalmologists solves clinical, computational challenges.

An international team of researchers has, for the first time, created a detailed map of the location and identity of individual cells in the adult lung, both from healthy lungs and in lungs from ...

The National Organization for Rare Disorders is a coalition of patient advocacy groups and the first national nonprofit that ...

In recent months China’s progress in artificial intelligence has stunned the world. A quieter, yet equally significant shift ...

The global clinical trials market was valued at USD 60.56 billion in 2024 and is predicted to surge USD 92.12 billion by 2033 with a registered CAGR of 4.84% during the forecast period 2024 to 2033.

The global Microcarriers market, valued at US$2.03 billion in 2023, is forecasted to grow at a robust CAGR of 8.0%, reaching US$2.08 billion ...

Four young children have gained life-changing improvements in sight following treatment with a pioneering new genetic ...

The evolution of cell and gene therapy is reshaping drug discovery, providing new hope for rare diseases and cancer through innovative gene editing approaches.

Vincent Gaynor remembers, almost to the minute, when he realized his part in birthing the breakthrough gene therapy Zolgensma ...